1. Fons, Nathan R, Sundaram, Ranjini K, Breuer, Gregory A, Brenner, Charles, Bindra, Ranjit S. 2019. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. In Nature communications, 10, 3790. doi:10.1038/s41467-019-11732-6. https://pubmed.ncbi.nlm.nih.gov/31439867/
2. Noronha, Katelyn J, Lucas, Karlie N, Paradkar, Sateja, Vasquez, Juan C, Bindra, Ranjit S. . NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. In Molecular cancer research : MCR, 22, 973-988. doi:10.1158/1541-7786.MCR-23-1003. https://pubmed.ncbi.nlm.nih.gov/38949523/
3. Chowdhry, Sudhir, Zanca, Ciro, Rajkumar, Utkrisht, Ren, Bing, Mischel, Paul S. 2019. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. In Nature, 569, 570-575. doi:10.1038/s41586-019-1150-2. https://pubmed.ncbi.nlm.nih.gov/31019297/
4. Wang, Niannian, Pan, Da, Wang, Xuemei, Sun, Guiju, Wang, Shaokang. 2022. NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. In Nutrients, 14, . doi:10.3390/nu14224916. https://pubmed.ncbi.nlm.nih.gov/36432602/
5. Li, Xiao-Qin, Lei, Jing, Mao, Lin-Hong, Zhou, Zhi-Hang, He, Song. 2019. NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer. In Frontiers in oncology, 9, 736. doi:10.3389/fonc.2019.00736. https://pubmed.ncbi.nlm.nih.gov/31448236/
6. Neves, Diogo, Goodfellow, Brian J, Vieira, Sandra I, Silva, Raquel M. 2022. The role of NAD metabolism in neuronal differentiation. In Neurochemistry international, 159, 105402. doi:10.1016/j.neuint.2022.105402. https://pubmed.ncbi.nlm.nih.gov/35843422/
智鼠故事 
